Emerging and reemerging fungal infections
Related Experiment Video
Updated: Jan 26, 2026

Author Spotlight: Investigating Fungal Pathogenicity Mechanisms in Maize
Published on: September 15, 2023
Shawn R Lockhart1, Jeannette Guarner2
1Mycotic Diseases Branch, Centers for Disease Control and Prevention 1600 Clifton Rd. Mailstop G-11, Atlanta, GA 30333, United States.
Abstract:
Fungal infections throughout the world appear to be increasing. This may in part be due to the increase in the population of patients that are susceptible to otherwise rare fungal infections resulting from the use of immune modulating procedures such as hematopoietic stem cell transplants and drugs like tissue necrosis factor antagonists. Histoplasma capsulatum, an endemic fungus throughout North and South America, is reemerging among HIV+ patients in Central and South America and among patients taking tissue necrosis factor antagonists and other biologics in North America. Fusarium species, a relatively rare fungal infection, is reemerging worldwide in the immunocompromised populations, especially those who are neutropenic like hematopoietic stem cell transplant recipients. A new yeast species is currently emerging worldwide: Candida auris, unknown just a decade ago. It is causing large healthcare-associated outbreaks on four continents and is spreading throughout the world through patient travel. In this review the epidemiology, pathology, detection and treatment of these three emerging and reemerging fungi will be discussed.
Insights
Emerging fungal infections like Histoplasma capsulatum, Fusarium, and Candida auris are increasing globally. These fungi pose significant threats to immunocompromised patients, particularly those undergoing stem cell transplants or using immune-modulating drugs.
Area of Science:
- Mycology
- Infectious Diseases
- Public Health
Background:
- Global increase in fungal infections observed.
- Rise attributed to growing populations of immunocompromised patients, including those receiving hematopoietic stem cell transplants and TNF antagonist therapies.
- Reemergence of endemic fungi like Histoplasma capsulatum and opportunistic pathogens such as Fusarium species in vulnerable populations.
Purpose of the Study:
- To review the epidemiology, pathology, detection, and treatment of three key emerging and reemerging fungal pathogens.
- To highlight the growing threat of Histoplasma capsulatum, Fusarium species, and Candida auris.
- To inform healthcare professionals about these significant fungal threats.
Main Methods:
- Literature review focusing on epidemiology, pathology, diagnostics, and therapeutics.
- Analysis of global trends in fungal infections.
- Case study review of emerging fungal species.
Main Results:
- Histoplasma capsulatum is reemerging in HIV+ patients and those on biologics.
- Fusarium species infections are increasing worldwide in immunocompromised individuals, especially neutropenic patients.
- Candida auris, a novel yeast, is causing widespread healthcare-associated outbreaks across multiple continents.
Conclusions:
- Emerging and reemerging fungal infections represent a significant and growing global health challenge.
- Effective detection and treatment strategies are crucial for managing these infections in at-risk populations.
- Continued surveillance and research are necessary to combat the increasing burden of fungal diseases.
Related Concept Videos
Emerging Adulthood
Fungal Group Zygomycota
Introduction Cardiac Emergencies
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Fungal Phylum Basidiomycota

